Neorabio-Home-Virtual Screening Service

Current Location: HOME> Technical Services> AI-Driven Drug R&D Services> Virtual Screening> Virtual Screening Service - Neorabio

Virtual Screening Service - Neorabio

Neorabio provides virtual screening solutions designed for discovery teams that need to evaluate large compound libraries quickly while retaining scientific rigor. Earlier analyses of structure-based screening challenges—such as those noted by Cheng et al. (2012)—emphasize that screening quality depends not only on algorithms but on how the computational workflow is planned, tuned, and monitored. Guided by this perspective, Neorabio structures each project around reproducible decision points rather than generic high-throughput automation.

About Service

Our workflow combines structure-based docking with ligand-derived models, choosing the appropriate approach for each target's structural context. Instead of relying on static pipelines summarized in prior methodology discussions (e.g., Lionta et al., 2014), Neorabio incorporates its own screening logic. This includes pose sanity checks, scoring-window calibration, cross-docking verification, and stability testing of ranking behavior. These refinements are executed on a distributed computing system capable of screening extensive libraries while maintaining transparent QC records for every batch.

Key Advantages

● Target-specific calibration: Adjustment of scoring ranges, pose-filter parameters, and threshold windows to reflect the unique structural environment of each protein target.
● Stable ranking outputs: Internal consistency checks reduce fluctuations between repeats and enhance interpretability of the final compound list.
● Robust library preprocessing: Custom filters for reactivity, structural alerts, physicochemical constraints, and assay-interference risks.
● Parallelized screening throughput: Distributed workload execution for rapid evaluation of large libraries without losing traceability.
● Clear decision pathways: Documented rationale for filtering, scoring, and compound selection criteria ensures reproducible downstream decisions.

Applications

● Hit exploration: Initial identification of candidates suitable for biochemical or biophysical assays.
● Target assessment: Evaluation of binding-site feasibility and compound–target compatibility before wet-lab commitment.
● Selectivity-driven prioritization: Parallel screening against related structures to reduce off-target risks early.
● Lead direction proposals: Supporting early medicinal chemistry decisions with interpretable computational evidence.
● Druggability insights: Structural evaluation of pockets and ligandability metrics to guide strategic project planning.

Workflow

Structure Submission → Structure Preprocessing → Parameter Setup → Docking Execution → Result Analysis → Report Delivery

References

1.Cheng T., Li Q., Zhou Z., Wang Y., Bryant S.H. Structure-based virtual screening for drug discovery: a problem-centric review. AAPS Journal. 2012;14(1):133–141. doi:10.1208/s12248-012-9322-0
2.Lionta E., Spyrou G., Vassilatis D.K., Cournia Z. Structure-based virtual screening: from classical to modern approaches. Current Topics in Medicinal Chemistry. 2014;14(16):1923–1938.
3.Ferreira L.G., Dos Santos R.N., Oliva G., Andricopulo A.D. Molecular docking and structure-based drug design strategies. Molecules. 2015;20(7):13384–13421. doi:10.3390/molecules200713384
4.Maia E.H.B., Assis L.C., da Silva A.M., Taranto A.G. Structure-based virtual screening: robust and useful tool for lead drug discovery. Molecules. 2020;25(5):1070. doi:10.3390/molecules25051070

Inquiry Center

Neorabio's computational chemistry group has worked across a broad range of target classes, enabling the team to recognize common pitfalls and design workflows that avoid them. Each project includes retrospective testing, randomization checks, pose review, and ranking-stability evaluation before results are released. These steps help ensure that recommended compounds are supported by transparent reasoning and can transition smoothly into downstream assay or medicinal chemistry programs.

NEORABIO

Technical Services

About Service

Key Advantages

Applications

Workflow

References

Inquiry Center